Leaflet immobility and thrombosis in transcatheter aortic valve replacement
Abstract. Transcatheter aortic valve replacement (TAVR) has grown exponentially worldwide in the last decade. Due to the higher bleeding risks associated with o
Related Articles
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure…
Cardiovascular Imaging in Pregnancy – American College of Cardiology
Transthoracic echocardiography and cardiac magnetic resonance imaging without contrast are first-line modalities for cardiac imaging in the setting of pregnancy. Appropriate diagnostic studies should not…
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity | Eli Lilly and Company
The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.
December 2024 Supplement – Endovascular Today
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
JACC in a Flash | JACC at AHA 2024; Rural America Faces Higher CV Death Risk; More – American College of Cardiology
Featured topics and Editors’ Picks from all of ACC’s JACC Journals. JACC and FDA Join Forces For CVD Research A new collaboration between JACC and…
Heart of Health Policy | ACC Advocacy Year in Review: Top 10 Highlights From 2024 – American College of Cardiology
ACC’s advocacy priorities for 2024 focused on establishing sustainable Medicare payment practices, fostering care transformation and optimization, bolstering the clinician workforce now and for the…
Feature | Expert Insights Into Managing Cardiotoxic Cancer Therapy – American College of Cardiology
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. To aid in achieving this objective, a three-part Expert…
Cover Story | Transformative Trends in CV Medicine For 2025 – American College of Cardiology
As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to…
ACC Mission in Action | Breaking Barriers and Empowering Mid-Career Women in Cardiology – American College of Cardiology
Keywords: Cardiology Magazine, ACC Publications, Leadership, Women, Women in Cardiology
From the Member Sections | The Evolution of Practice in Structural Disease/Valve Treatment: A Triumph of Collaboration – American College of Cardiology
The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977. Despite careful lesion selection, the initial equipment consisted of…